MI
JAZZ icon

Markowski Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Markowski Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.82K Buy
+20
New +$4.38K ﹤0.01% 475

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Markowski Investments's JAZZ Position: Q2 2026 in Review

Markowski Investments opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 20 shares worth $4.82K. The stake represents ﹤0.01% of the portfolio and ranks #475 among its holdings.

488 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Markowski Investments held 20 shares of Jazz Pharmaceuticals worth $4.82K as of Q2 2026.
  • Jazz Pharmaceuticals was a new Markowski Investments position in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Markowski Investments's portfolio in Q2 2026, its #475 holding.
  • 488 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Markowski Investments's 13F filing for Q2 2026, filed 13 Aug 2026.